Literature DB >> 12154127

The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Yuying Liang1, Jean Chang, Stephen J Lynch, David M Lukac, Don Ganem.   

Abstract

The RTA protein of the Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is responsible for the switch from latency to lytic replication, a reaction essential for viral spread and KS pathogenesis. RTA is a sequence-specific transcriptional activator, but the diversity of its target sites suggests it may act via interaction with host DNA-binding proteins as well. Here we show that KSHV RTA interacts with the RBP-Jkappa protein, the primary target of the Notch signaling pathway. This interaction targets RTA to RBP-Jkappa recognition sites on DNA and results in the replacement of RBP-Jkappa's intrinsic repressive action with activation mediated by the C-terminal domain of RTA. Mutation of such sites in target promoters strongly impairs RTA responsiveness. Similarly, such target genes are induced poorly or not at all by RTA in fibroblasts derived from RBP-Jkappa(-/-) mice, a defect that can be reversed by expression of RBP-Jkappa. In vitro, RTA binds to two adjacent regions of RBP-Jkappa, one of which is identical to the central repression domain that binds the Notch effector fragment. These results indicate that KSHV has evolved a ligand-independent mechanism for constitutive activation of the Notch pathway as a part of its strategy for reactivation from latency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154127      PMCID: PMC186409          DOI: 10.1101/gad.996502

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  54 in total

1.  Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.

Authors:  C Boshoff; Y Endo; P D Collins; Y Takeuchi; J D Reeves; V L Schweickart; M A Siani; T Sasaki; T J Williams; P W Gray; P S Moore; Y Chang; R A Weiss
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

2.  Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2.

Authors:  A J Capobianco; P Zagouras; C M Blaumueller; S Artavanis-Tsakonas; J M Bishop
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.

Authors:  J J Hsieh; D E Nofziger; G Weinmaster; S D Hayward
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

Authors:  J Nicholas; V R Ruvolo; W H Burns; G Sandford; X Wan; D Ciufo; S B Hendrickson; H G Guo; G S Hayward; M S Reitz
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

5.  Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue.

Authors:  R Sarid; T Sato; R A Bohenzky; J J Russo; Y Chang
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

6.  A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak.

Authors:  E H Cheng; J Nicholas; D S Bellows; G S Hayward; H G Guo; M S Reitz; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

7.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

8.  Human herpesvirus 8 encodes a homolog of interleukin-6.

Authors:  F Neipel; J C Albrecht; A Ensser; Y Q Huang; J J Li; A E Friedman-Kien; B Fleckenstein
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.

Authors:  C Bais; B Santomasso; O Coso; L Arvanitakis; E G Raaka; J S Gutkind; A S Asch; E Cesarman; M C Gershengorn; E A Mesri; M C Gerhengorn
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

10.  CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex.

Authors:  J J Hsieh; S Zhou; L Chen; D B Young; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

View more
  149 in total

1.  Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells.

Authors:  Kathryn Austgen; Scott A Oakes; Don Ganem
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling.

Authors:  Min Jie Alvin Tan; Elizabeth A White; Mathew E Sowa; J Wade Harper; Jon C Aster; Peter M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

3.  Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.

Authors:  Yi Jin; Zhiheng He; Deguang Liang; Quanzhi Zhang; Hongxing Zhang; Qiang Deng; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Authors:  Katharina Heinzelmann; Barbara A Scholz; Agnes Nowak; Even Fossum; Elisabeth Kremmer; Juergen Haas; Ronald Frank; Bettina Kempkes
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.

Authors:  Jiguo Chen; Fengchun Ye; Jianping Xie; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

6.  Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies.

Authors:  Abel Viejo-Borbolla; Matthias Ottinger; Thomas F. Schulz
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

7.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Murine Gammaherpesvirus 68 ORF48 Is an RTA-Responsive Gene Product and Functions in both Viral Lytic Replication and Latency during In Vivo Infection.

Authors:  Jing Qi; Chuanhui Han; Danyang Gong; Ping Liu; Sheng Zhou; Hongyu Deng
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

10.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.